+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Cell and Gene Therapy World Market and Market Potential - Product Thumbnail Image

Cell and Gene Therapy World Market and Market Potential

  • Report
  • February 2022
  • 272 Pages
  • Global
From
From
From
Argentina Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Argentina Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • October 2022
  • 73 Pages
  • Argentina
From
From
From
Canada Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Canada Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • September 2022
  • 77 Pages
  • Canada
From
Turkey Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Turkey Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • September 2022
  • 82 Pages
  • Turkey
From
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
TRAIL Receptor 2 Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

TRAIL Receptor 2 Agonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator